POS0653 IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY
Mysler, E., Tanaka, Y., Kavanaugh, A., Aletaha, D., Taylor, P. C., Song, I. H., Shaw, T., Song, Y., Demasi, R., Ali, M., Fleischmann, R.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
Colombo, M, Fernández, I, Abdurakhmanov, D, Ferreira, P A, Strasser, S I, Urbanek, P, Moreno, C, Streinu-Cercel, A, Verheyen, A, Iraqi, W, DeMasi, R, Hill, A, Läuffer, J M, Lonjon-Domanec, I, Wedemeyer, H
Published in Gut (01.07.2014)
Published in Gut (01.07.2014)
Get full text
Journal Article
SAT0234 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 9 years
Wollenhaupt, J., Silverfield, J., Lee, E. B., Terry, K., Kwok, K., Strengholt, S., DeMasi, R., Wang, L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
OP0037 Efficacy of tofacitinib after temporary discontinuation in patients with rheumatoid arthritis: analysis of data from open-label long-term extension studies
Kaine, J., Tesser, J., DeMasi, R., Takiya, L., Wang, L., Snyder, M., Fan, H., Bandi, V., Wollenhaupt, J.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
SAT0256 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: patient-reported outcomes from a phase 3b/4 randomised trial
Strand, V., Mysler, E., Moots, R.J., Wallenstein, G., DeMasi, R., Gruben, D., Soma, K., Iikuni, N., Fleischmann, R.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis
El Raziky, M., Gamil, M., Ashour, M. K., Sameea, E. A., Doss, W., Hamada, Y., Van Dooren, G., DeMasi, R., Keim, S., Lonjon‐Domanec, I., Hammad, R., Hashim, M. S., Hassany, M., Waked, I.
Published in Journal of viral hepatitis (01.02.2017)
Published in Journal of viral hepatitis (01.02.2017)
Get full text
Journal Article
THU0299 An integrated analysis of changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis across phase 3 and long-term extension studies
Gladman, D.D., Charles-Schoeman, C., McInnes, I.B., Veale, D.J., Thiers, B., Graham, D., Wang, C., Jones, T.V., Wolk, R., DeMasi, R.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
SAT0111 Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates
Schwartzman, S., van Vollenhoven, R., Matsumoto, A., Orange, D., Shah, S., DeMasi, R., Fan, H., Dahl, P., Wouters, A., Keystone, E.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
SAT0243 Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes
Mease, P.J., Kremer, J., Cohen, S., Curtis, J.R., Charles-Schoeman, C., Loftus, E.V., Greenberg, J., Palmetto, N., Kanik, K. S., Graham, D., Wang, C., Biswas, P., Chan, G., DeMasi, R., Valdez, H., Hendrikx, T., Jones, T. V.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
THU0180 Lack of Early Change in Disease Activity Score Predicts The Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy versus Methotrexate in Methotrexate-Naïve Patients with Rheumatoid Arthritis
Keystone, E., van Vollenhoven, R.F., Wilkinson, B., Fallon, L., Hwang, L.-J., Chapman, D., DeMasi, R., Lee, E.B.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
Wollenhaupt, J., Silverfield, J., Lee, E.B., Terry, K.K., Kwok, K., Lazariciu, I., Nduaka, C., Connell, C.A., DeMasi, R., Wang, L.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis
Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Figure-of-eight Measurements Show High Reliability in A Clinical Setting in Assessing Edema in Patients With Hand Injuries
Lewis, E.S, Jones, M, DeMasi, R, Tabor, N, Howley, A
Published in Journal of hand therapy (01.07.2016)
Published in Journal of hand therapy (01.07.2016)
Get full text
Journal Article
P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER
Palescandolo, E, Vijgen, L, Talloen, W, Colombo, M, Mangia, A, Wedemeyer, H, Demasi, R, Lonjon-Domanec, I, Aerssens, J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS
Zeuzem, S, Demasi, R, Foster, G.R, Buti, M, Baldini, A, Luo, D, Witek, J, Rizzetto, M
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1346 : Study protocol for a partly randomised, open-label phase IIA trial of once-daily simeprevir combined with sofosbuvir for the treatment of HCV genotype 4 infected patients with or without cirrhosis (OSIRIS)
El Raziky, M, Gamil, M, Hammad, R, Hashem, M.S, Hassany, M, Khairy, M, El Sharkawy, A, Gomaa, A, Keim, S, Van Dooren, G, DeMasi, R, Lonjon-Domanec, I, Doss, W, Waked, I
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2
Melby, T, Sista, P, DeMasi, R, Kirkland, T, Roberts, N, Salgo, M, Heilek-Snyder, G, Cammack, N, Matthews, T J, Greenberg, M L
Published in AIDS research and human retroviruses (01.05.2006)
Published in AIDS research and human retroviruses (01.05.2006)
Get more information
Journal Article
P1209 FACTORS INFLUENCING RENAL FUNCTION IN PATIENTS RECEIVING TELAPREVIR TWICE DAILY OR EVERY 8 HOURS: RESULTS FROM THE PHASE III OPTIMIZE STUDY
Buti, M, Agarwal, K, Horsmans, Y, Sievert, W, Janczewska, E, Zeuzem, S, Nyberg, L, Brown, R.S, Hezode, C, Rizzetto, M, Parana, R, De Meyer, S, Demasi, R, Luo, D, Bertelsen, K, Witek, J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1210 PREDICTORS OF SVR24 FOR 1078 PATIENTS WITH SEVERE FIBROSIS OR COMPENSATED CIRRHOSIS: THE INTERNATIONAL TELAPREVIR ACCESS PROGRAM
Colombo, M, Strasser, S.I, Moreno, C, Ferreira, P.A, Urbanek, P, Fernández, I, Abdurakhmanov, D, Streinu-Cercel, A, Verheyen, A, Iraqi, W, Demasi, R, Hill, A, Lonjon-Domanec, I, Wedemeyer, H
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article